Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity
Acta Diabetologica · 04.07.2024 · 61 (12) · 1577-1588
DOI: 10.1007/s00592-024-02325-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 04.07.2024. Verfasst von Ayman Hyder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Damietta University, New Damietta, 34517, Egypt. hyder@du.edu.eg. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Fatty Acid Binding Protein 3, Gene Silencing, Fatty Acids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology & Innovation Funding Authority (STDF), Egypt, Damiatta University.
Abstract (Originalsprache)
Background
Long-term exposure of pancreatic islets to fatty acids (FAs), common in obesity, metabolic syndrome, and type 2 diabetes, leads to a compensatory hyperactivity followed by inflammation, apoptosis, dysfunctional beta cells, and results in insulin dependence of the patient. Restriction of fatty uptake by islet beta cells may protect them from lipotoxicity.
Purpose
Pancreatic islet beta cells express the fatty acid binding protein 3 (FABP3) to bind FAs and to orchestrate lipid signals. Based on this, we investigated whether downregulation of FABP3, by Fabp3 silencing, might slow lipid metabolism and protect against lipotoxicity in insulin-secreting cells.
Results
Neither Fabp3 silencing, nor overexpression affected the glucose-stimulated insulin secretion in absence of FAs. Fabp3 silencing decreased FA-uptake, lipid droplets formation, and the expression of the lipid accumulation-regulating gene Dgat1 in Ins1E cells. It reduced FA-induced inflammation by deactivation of NF-κB, which was associated with upregulation of IκBα and deactivation of the NF-κB p65 nuclear translocation, and the downregulation of the cytokines ILl-6, IL-1β, and TNFα. Ins1E cells were protected from the FA-induced apoptosis as assessed by different parameters including DNA degradation and cleaved caspase-3 immunoblotting. Furthermore, FABP3 silencing improved the viability, Pdx1 gene expression, and the insulin-secreting function in cells long-term cultured with palmitic acid. All results were confirmed by the opposite action rendered by FABP3 overexpression.
Conclusion
The present data reveals that pancreatic beta cells can be protected from lipotoxicity by inhibition of FA-uptake, intracellular utilization and accumulation. FABP3 inhibition, hence, may be a useful pharmaceutical approach in obesity, metabolic syndrome, and type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Damietta University, New Damietta, 34517, Egypt. hyder@du.edu.eg.
- Faculty of Science, Damietta University, New Damietta, 34517, Egypt.
- Faculty of Medicine, Johannes Gutenberg University, Mainz, Germany.
Förderung
- Science, Technology & Innovation Funding Authority (STDF), Egypt
- Damiatta University
Zitieren
APA
Hyder, A., Sheta, B., Eissa, M., & Schrezenmeir, J. (2024). Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity. Acta Diabetologica, 61(12), 1577-1588. https://doi.org/10.1007/s00592-024-02325-x
Vancouver
Hyder A, Sheta B, Eissa M, Schrezenmeir J. Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity. Acta Diabetologica. 2024;61(12):1577-1588. doi:10.1007/s00592-024-02325-x
BibTeX
@article{Hyder2024,
author = {Hyder, Ayman and Sheta, Basma and Eissa, Manar and Schrezenmeir, Jürgen},
title = {Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity},
journal = {Acta Diabetologica},
year = {2024},
volume = {61},
number = {12},
pages = {1577--1588},
doi = {10.1007/s00592-024-02325-x}
}
EUVIMED